Protalex Inc (PRTX) financial statements (2021 and earlier)

Company profile

Business Address 131 COLUMBIA TURNPIKE
FLORHAM PARK, NJ 07932
State of Incorp. DE
Fiscal Year End May 31
SIC 8731 - Commercial Physical and Biological Research (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

8/31/2018
Q1
5/31/2018
Q4
2/28/2018
Q3
11/30/2017
Q2
8/31/2017
Q1
5/31/2017
Q4
2/28/2017
Q3
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments0110001
Cash and cash equivalents0110001
Prepaid expense0000000
Total current assets:0120111
Noncurrent Assets
Intangible assets, net (including goodwill)0000000
Intangible assets, net (excluding goodwill)0000000
Total noncurrent assets:0000000
TOTAL ASSETS:0120111
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1111111
Accounts payable0011101
Accrued liabilities0000000
Due to related parties   22   
Other undisclosed current liabilities   2   
Total current liabilities:11124111
Noncurrent Liabilities
Long-term debt and lease obligation00     
Long-term debt, excluding current maturities00     
Liabilities, other than long-term debt22  212019
Due to related parties22  212019
Other undisclosed noncurrent liabilities002 211
Total noncurrent liabilities:222 232221
Total liabilities:33324232221
Stockholders' equity
Stockholders' equity attributable to parent(3)(2)(1)(24)(23)(22)(21)
Common stock0000000
Additional paid in capital10210210277777777
Accumulated deficit(105)(104)(103)(101)(100)(99)(98)
Total stockholders' equity:(3)(2)(1)(24)(23)(22)(21)
TOTAL LIABILITIES AND EQUITY:0120111

Income statement (P&L) ($ in millions)

8/31/2018
Q1
5/31/2018
Q4
2/28/2018
Q3
11/30/2017
Q2
8/31/2017
Q1
5/31/2017
Q4
2/28/2017
Q3
Operating expenses(1)(1)(1)(1)(1)(1)(1)
Other undisclosed operating loss(0)(0)(0)(0)(0)(0)(0)
Operating loss:(1)(1)(2)(1)(1)(1)(1)
Nonoperating income
(Investment Income, Nonoperating)
0000000
Interest and debt expense(0)(0)(0)(0)(0)(0)(0)
Net loss available to common stockholders, diluted:(1)(1)(2)(1)(1)(1)(1)

Comprehensive Income ($ in millions)

8/31/2018
Q1
5/31/2018
Q4
2/28/2018
Q3
11/30/2017
Q2
8/31/2017
Q1
5/31/2017
Q4
2/28/2017
Q3
Net loss:(1)(1)(2)(1)(1)(1)(1)
Comprehensive loss, net of tax, attributable to parent:(1)(1)(2)(1)(1)(1)(1)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: